References
- Palella Jr FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New England Journal of Medicine. 1998; 338(13): 853-60. PubMed | Google Scholar
- UNAIDS. How
AIDS changed everything. Accessed on 26 November 2016.
- UNAIDS. The
HIV and AIDS Uganda Country Progress Report 2014. Accessed on 6
October 2015.
- Uganda AIDS Commission. HIV
and AIDS Uganda Country Progress Report 2013. Accessed on 6 October
2015.
- Hogg RS, Yip B, Kully C, Craib KJ, O'shaughnessy MV, Schechter MT. Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens. Canadian Medical Association Journal. 1999; 160(5): 659-65. PubMed | Google Scholar
- Hirschel B, Opravil M. The year in review: antiretroviral treatment. AIDS (London, England). 1999; 13 Suppl A: S177-87. PubMed | Google Scholar
- Notermans DW, Jurriaans S, de Wolf F, Foudraine NA, de Jong JJ, Cavert W. Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine. Aids. 1998; 12(2): 167-73. PubMed | Google Scholar
- Gulick RM, Mellors JW, Havlir D, Eron JJ, Gonzalez C, McMahon D. Treatment with indinavir, zidovudine and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. New England Journal of Medicine. 1997; 337(11): 734-9. PubMed | Google Scholar
- Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Annals of internal Medicine. 2002 Sep 3; 137(5 Pt 2): 381-433. PubMed | Google Scholar
- Carpenter CC, Cooper DA, Fischl MA, Gatell JM, Gazzard BG, Hammer SM. Antiretroviral therapy in adults: updated recommendations of the International AIDS Society?USA Panel. Jama. 2000; 283(3): 381-90. PubMed | Google Scholar
- Flexner C. HIV-protease inhibitors. New England Journal of Medicine. 1998; 338(18): 1281-93. PubMed | Google Scholar
- DeGruttola V, Dix L, D'Aquila R, Holder D, Phillips A, Ait-Khaled M. The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan. Antiviral therapy. 2000; 5(1): 41-8. PubMed | Google Scholar
- Ministry of Health Uganda. Addendum
to the National Antiretroviral Treatment Guidelines
for Uganda. 2013.
Accessed on 3 February 2017.
- Katzenstein DA, Hammer SM, Hughes MD, Gundacker H, Jackson JB, Fiscus S. The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. New England Journal of Medicine. 1996; 335(15): 1091-8. PubMed | Google Scholar
- Kaufmann GR, Perrin L, Pantaleo G, Opravil M, Furrer H, Telenti A. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study. Archives of internal medicine. 2003; 163(18): 2187-95. PubMed | Google Scholar
- Moore RD, Keruly JC, Gebo KA, Lucas GM. An improvement in virologic response to highly active antiretroviral therapy in clinical practice from 1996 through 2002. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2005; 39(2): 195-8. PubMed | Google Scholar
- Powderly WG, Saag MS, Chapman S, Yu G, Quart B, Clendeninn NJ. Predictors of optimal virological response to potent antiretroviral therapy. Aids. 1999; 13(14): 1873-80. PubMed | Google Scholar
- Mellors JW, Rinaldo Jr CR, Gupta P, White RM. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 1996; 272(5265): 1167. PubMed | Google Scholar
- O'brien WA, Hartigan PM, Martin D, Esinhart J, Hill A, Benoit S et al. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. New England Journal of Medicine. 1996; 334(7): 426-31. PubMed | Google Scholar
- Piacenti FJ. An update and review of antiretroviral therapy. Pharmacotherapy: the Journal of Human Pharmacology and Drug Therapy. 2006; 26(8): 1111-33. PubMed | Google Scholar
- Deeks SG. Determinants of virological response to antiretroviral therapy: implications for long-term strategies. Clinical Infectious Diseases. 2000; 30(Supplement 2): S177-S84. PubMed | Google Scholar
- Keiser O, Tweya H, Boulle A, Braitstein P, Schechter M, Brinkhof MW et al. Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring. AIDS (London, England). 2009; 23(14): 1867. PubMed | Google Scholar
- Llibre JM, Cardona G, Santos JR, Andreu A, Estrada JO, Ara J et al. Antiretroviral treatment switch strategies for lowering the costs of antiretroviral therapy in subjects with suppressed HIV-1 viremia in Spain. Clinicoecon Outcomes Res. 2013; 5: 215-21. PubMed | Google Scholar
- Morgan D, Malamba SS, Maude GH, Okongo MJ, Wagner H-U, Mulder DW. An HIV-1 natural history cohort and survival times in rural Uganda. Aids. 1997; 11(5): 633-40. PubMed | Google Scholar
- Ministry of Health Uganda. National Antiretroviral Treatment
and Care Guidelines for Adults and Children First
Edition 2003.
Accessed on February 3 2017.
- Ministry of Health Uganda. Uganda Clinical Guidelines 2003-National Guidelines on Management of Common Conditions, First Edition 2003. Accessed on February 3 2017.
- Victora CG, Huttly SR, Fuchs SC, Olinto M. The role of conceptual frameworks in epidemiological analysis: a hierarchical approach. International journal of epidemiology. 1997; 26(1): 224-7. PubMed | Google Scholar
- El-Khatib Z, Katzenstein D, Marrone G, Laher F, Mohapi L, Petzold M. Adherence to drug-refill is a useful early warning indicator of virologic and immunologic failure among HIV patients on first-line ART in South Africa. PLoS One. 2011; 6(3): e17518. PubMed | Google Scholar
- Pujades-Rodriguez M, O'brien D, Humblet P, Calmy A. Second-line antiretroviral therapy in resource-limited settings: the experience of Medecins Sans Frontieres. AIDS. 2008; 22(11): 1305-12. PubMed | Google Scholar
- Kawuma R, Bernays S, Siu G, Rhodes T, Seeley J. "Children will always be children": exploring perceptions and experiences of HIV-positive children who may not take their treatment and why they may not tell. African Journal of AIDS Research. 2014; 13(2): 189-95. PubMed | Google Scholar
- Charurat M, Oyegunle M, Benjamin R, Habib A, Eze E, Ele P. Patient retention and adherence to antiretrovirals in a large antiretroviral therapy program in Nigeria: a longitudinal analysis for risk factors. PLoS One. 2010; 5(5): e10584. PubMed | Google Scholar
- Petersen ML, Tran L, Geng EH, Reynolds SJ, Kambugu A, Wood R. Delayed switch of antiretroviral therapy after virologic failure associated with elevated mortality among HIV-infected adults in Africa. AIDS (London, England). 2014; 28(14): 2097. PubMed | Google Scholar
- Kalichman SC, Grebler T, Amaral CM, McNerey M, White D, Kalichman MO. Intentional non-adherence to medications among HIV positive alcohol drinkers: prospective study of interactive toxicity beliefs. Journal of general internal medicine. 2013; 28(3): 399-405. PubMed | Google Scholar
- Kalichman SC, Grebler T, Amaral CM, McNerney M, White D, Kalichman MO et al. Viral suppression and antiretroviral medication adherence among alcohol using HIV-positive adults. International journal of behavioral medicine. 2014; 21(5): 811-20. PubMed | Google Scholar
- Kekwaletswe CT, Morojele NK. Alcohol use, antiretroviral therapy adherence and preferences regarding an alcohol-focused adherence intervention in patients with human immunodeficiency virus. Patient Preference & Adherence. 2014 Mar 31; 8: 401-13. PubMed | Google Scholar
- Idindili B, Jullu B, Mugusi F, Tanner M. A case-control study of factors associated with non-adherence to antiretroviral therapy among HIV infected people in Pwani Region, Eastern Tanzania. Tanzania journal of health research. 2012 Jul; 14(3): 194-203. PubMed | Google Scholar
- Meriki HD, Tufon KA, Afegenwi MH, Nyindem BA, Atanga PN, Anong DN. Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon. Infectious Diseases of Poverty. 2014; 3(1): 5. PubMed | Google Scholar
- Ogoina D, Obiako RO, Muktar HM, Adeiza M, Babadoko A, Hassan A et al. Morbidity and mortality patterns of hospitalised adult HIV/AIDS patients in the era of highly active antiretroviral therapy: a 4-year retrospective review from Zaria, Northern Nigeria. AIDS research and treatment. 2012; 2012: 940580. PubMed | Google Scholar